New year, good news! We are happy to announce that our another pharmaceutical excipient Yellow Beeswax has been activated, and the CDE registration status has changed from “I” to “A”, which means that it is approved by NMPA to be used in marketed preparations. More detailed information can be found in National Medical Products Adm壯陽藥
inistration Drug Evaluation Center.
Thanks to our refined technology, our yellow beeswax has high purity, low peroxide value and small difference between batches. It has excellent stability, which can help to improve the compatibility with APIs and the stability of formulations. As a multifunctional pharmaceutical excipient, yellow beeswax can be used as matrix in ointment, suspending agent in soft capsules and sustained-release agent in tablets and suppositories.
The successful activation of the registration status of Fumei’s high-quality yellow beeswax provides a new choice for the pharmaceutical industry. As a professional supplier of pharmaceutical excipients for oral and topical preparations, Fumei will continue to supply high-quality products and all-round solutions to our customers, and provide support for their independent innovation, thus promoting the sustainable development of the pharmaceutical industry.
